Overcoming the efficacy-safety dilemma of cytokine therapy for tissue-resident memory T cells in cancer immunotherapy: Intrinsic sensitization and extrinsic optimization.
Tissue-resident memory T (TRM) cells are important contributors to immune checkpoint blockade therapy response in several cancers, yet their therapeutic potential remains underutilized. The cytokine-mediated enhancement of TRM cells represents a promising strategy to amplify antitumor immunity. However, clinical transl...